MoonLake Immunotherapeutics ( MLTX) - Stock Earnings
MLTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
MLTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -62.4 million USD | — USD |
| 2026Q1 | -69.7 million USD | — USD |
| 2026Q2 | -61.8 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MLTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -36.0 million USD | — USD |
| 2024 | -118.9 million USD | — USD |
| 2025 | -227.3 million USD | — USD |
| 2026 Est. | — | — |
MLTX
Price: $9.60
52 week price:
Earnings Per Share: -3.84 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 959.8 million